CAPR - CAPRICOR THERAPEUTICS, INC.
IEX Last Trade
14.235
0.165 1.159%
Share volume: 11,998
Last Updated: Fri 27 Dec 2024 08:29:59 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$14.07
0.17
1.17%
Summary score
22%
Profitability
25%
Dept financing
11%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-682.87%
Return on assets
-23.42%
Return on sales
-503.39%
Return on invested capital
227.54%
Total debt ratio
68.7%
Debt ratio change over timeo
-0.18%
Current Ratio
7.1%
Quick Ratio
0%
Cash Position Ratio
4.76%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-24.81%
Return on assets
-14.52%
Return on sales
0%
Return on invested capital
358.22%
Total debt ratio
35.23%
Debt ratio change over timeo
-0.89%
Current Ratio
12.2%
Quick Ratio
0%
Cash Position Ratio
10.14%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-11.01%
Return on assets
-9.39%
Return on sales
0%
Return on invested capital
259.25%
Total debt ratio
14.74%
Debt ratio change over time
-0.94%
Current Ratio
19.06%
Quick Ratio
0%
Cash Position Ratio
18.91%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-632.22%
Return on assets
-121.5%
Return on sales
-257.34%
Return on invested capital
-426.45%
Total debt ratio
-18.15%
Debt ratio change over time
-0.18%
Current Ratio
4.71%
Quick Ratio
0%
Cash Position Ratio
2.07%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CAPR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -682.87% | -3.05% | 11.55% | 6.27% |
| Return on assets | -23.42% | 3.6% | 3.57% | 5.27% |
| Return on sales | -503.39% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 227.54% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 60% |
| Total debt ratio | 68.7% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.18% | 6.09% | 6.03% | 1.53% |
| Dept financing | 17% | 50% | 43% | 14% |
| Current Ratio | 12.2% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 10.14% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 19% | 41% | 42% |
| Short-term ratios | CAPR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -24.81% | -25.62% | 17.94% | 7.14% |
| Return on assets | -14.52% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 358.22% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 70% | 59% |
| Total debt ratio | 35.23% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.89% | -23.44% | 9.66% | 0.6% |
| Dept financing | 8% | 25% | 45% | 8% |
| Current Ratio | 12.2% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 10.14% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 25% | 21% | 36% |